Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.

  1. Olaso, E.
  2. Vidal-Vanaclocha, F.
Aldizkaria:
Methods in molecular medicine

ISSN: 1543-1894

Argitalpen urtea: 2003

Alea: 85

Orrialdeak: 79-86

Mota: Berrikuspena

DOI: 10.1385/1-59259-380-1:79 GOOGLE SCHOLAR